WAYNE, Pa.--(BUSINESS WIRE)--Aug. 18, 2016--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies for critical care and surgery, has today announced its
support of the Difficult Airway Society with the launch of the first
research grant directed to ADEPT Guidance. The research grant, which
will be funded by Teleflex and administered by the Difficult Airway
Society, will support the evaluation of second-generation SADs.
While there are both national and international regulations governing
the marketing and sale of airway management devices, until now there has
been little formal guidance relating to their selection. The ADEPT
Guidance is a proposed professional standard that was developed by the
Airway Device Evaluation Project Team of the DAS in 2011 to establish a
process of formal product evaluation for airway management devices to
support purchasing decisions.1 ADEPT Guidance emphasizes
evidence-based principles and defines a minimum level of evidence needed
to make pragmatic decisions about the purchase or selection of an airway
device. To date, no airway management devices have been specifically
evaluated in accordance with ADEPT Guidance.
“This inaugural DAS research grant marks the first time ADEPT guidance
has been specifically adopted in the evaluation of airway management
products,” said Michelle Fox, RN, BSN, Vice President, Clinical and
Medical Affairs, Teleflex. “As a leading global provider of innovative
airway management solutions, Teleflex welcomes high caliber product
testing and evaluation and is proud to be supporting this DAS initiative
by way of a research grant.”
The terms of the grant provide that all discoveries resulting from work
supported by the grant are to be made available to the public and
scientific community through approved scientific channels such as
national meetings and peer-reviewed publications.
About the Difficult Airway Society
The Difficult Airway Society is a UK-based medical specialist society
formed as a registered charity to further management of the airway of
patients by anesthetists and other critical care practitioners. Its aims
are to promote research and the development of new techniques in dealing
with airway problems and to advance public education in the science and
practice of the management of patients with difficult or unusual airway
problems, by the conduct of courses, lectures, demonstrations, and by
ensuring that due attention is paid to airway management techniques in
the training curricula of medical and paramedical practitioners. With
almost 3,000 members, it is one of the largest anesthetic specialist
societies in the UK.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply
purpose-driven innovation – a relentless pursuit of identifying unmet
clinical needs – to benefit patients and healthcare providers. Our
portfolio is diverse, with solutions in the fields of vascular and
interventional access, surgical, anesthesia, cardiac care, urology,
emergency medicine and respiratory care. Teleflex employees worldwide
are united in the understanding that what we do every day makes a
difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rüsch®
and Weck® – trusted brands united by a common sense of
purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch and Weck are trademarks or registered trademarks of
Teleflex Incorporated or its affiliates, in the U.S. and/or other
countries. © 2016 Teleflex Incorporated. All rights reserved. MC-002136
References:
1. Pandit JJ, Popat MT, Cook TM et al. The Difficult Airway Society
'ADEPT' guidance on selecting airway devices: the basis of a strategy
for equipment evaluation. Anaesthesia 2011;66(8):726–737.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160818005060/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836
jake.elguicze@teleflex.com
www.teleflex.com